Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts

Transplantation

Volumn 69, Issue 9, 2000, Pages 1806-1812

  Sutherland, Robyn M ^b   Brady, Jamie L ^b   Georgiou, Harry M ^a,b   Thomas, Helen E ^b   Lew, Andrew M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TRANSGENE;

EID: 0034658452     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200005150-00013     Document Type: Article

References (24)

1. Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokine messenger RNA stability by a surface-mediated T-cell activation pathway. Science 1989; 244: 339.
2. Thompson CB, Lindsten T, Ledbetter JA, et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 1989; 86: 1333.
3. Gribben JG, Freeman GJ, Boussiotis VA, et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995; 92: 811.
4. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation [See comments]. J Exp Med 1995; 182: 459.
5. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
6. Lenschow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 1995; 181: 1145.
7. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
8. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992; 257: 789.
9. Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Transplantation 1995; 59: 1313.
10. Lew AM, Brady JL, Silva A, Coligan JE, Georgiou HM. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen. Transplantation 1996; 62: 83.
11. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995; 155: 1165.
12. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 1997; 63: 1017.
13. Gainer AL, Suarez-Pinzon WL, Min WP, et al. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand. Transplantation 1998; 66: 194.
14. Martin RM, Silva A, Lew AM. The Igh-1 sequence of the nonobese diabetic (NOD) mouse assigns it to the IgG2c isotype. Immunogenetics 1997; 46: 167.
15. Boyle JS, Brady JL, Lew AM. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998; 392: 408.
16. Martin RM, Brady JL, Lew AM. The need for IgG2c specific antiserum when isotyping antibodies from C57Bl/6 and NOD mice. J Immunol Methods 1998; 212: 187.
17. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985; 315: 115.
18. Mandel TE, Koulmanda M. Islet isolation from the fetal pancreas. In: Lanza P, Chick WL, eds. Procurement of pancreatic islets, Vol 1. Austin, TX: Landes Company, 1994: 107.
19. Mandel TE, Dillon H, Koulmanda M. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice. Transplant Immunol 1995; 3: 265.
20. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF. Successful biolistic transformation of mouse pancreatic islets while preserving cellular function. Transplantation 1996; 61: 1567.
21. Prince HM. Gene transfer: a review of methods and applications. Pathology 1998; 30: 335.
22. Schiedner G, Morral N, Parks RJ, et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature Gen 1998; 18: 180.
23. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen: memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994; 152: 2675.
24. Cuthbertson RA, Mandel TE. A comparison of portal versus systemic venous drainage in murine foetal pancreatic islet transplantation. Aust J Exp Biol Med Sci 1986; 64: 175.